HRTX - Heron Therapeutics EPS misses by $0.01 beats on revenue November, 05 2020 08:37 AM Heron Therapeutics Inc. Heron Therapeutics (HRTX): Q3 GAAP EPS of -$0.64 misses by $0.01.Revenue of $19.97M (-53.1% Y/Y) beats by $2.79M.Press Release For further details see: Heron Therapeutics EPS misses by $0.01, beats on revenue